Am J Perinatol 2019; 36(04): 440-442
DOI: 10.1055/s-0038-1669441
Commentary
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Impact of the New American Hypertension Guidelines on the Prevalence of Postpartum Hypertension

Graeme N. Smith
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Kingston Health Sciences Centre, Queen's University, Kingston, Canada
,
Jessica Pudwell
1   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Kingston Health Sciences Centre, Queen's University, Kingston, Canada
,
George R. Saade
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, Texas
› Institutsangaben
Weitere Informationen

Publikationsverlauf

17. Mai 2018

23. Juli 2018

Publikationsdatum:
31. August 2018 (online)

Abstract

Cardiovascular disease (CVD) is the leading cause of death and disability among women, with more than half occurring in individuals with hypertension. New blood pressure criteria for the diagnosis of hypertension from the American College of Cardiology/American Heart Association recognize that there is no specific blood pressure threshold that is associated with vascular disease. We performed a secondary analysis of two published postpartum databases (the Pre-Eclampsia New Emerging Team [PE-NET] cohort and the Maternal Health Clinic [MHC] cohort) to determine the impact of the change in blood pressure criteria on the diagnosis of hypertension. The prevalence of hypertension in women with uncomplicated pregnancies (PE-NET control) was 22% compared with 56.4% in those who have had a pregnancy complicated by preeclampsia (PE, PE-NET patient) and 67.2% in those referred to the MHC due to a pregnancy complicated by any of the hypertensive disorders of pregnancy. It is well established that certain complications in pregnancy can reliably identify women with risk factors for future CVD. Thus, pregnancy and the postpartum afford a new opportunity for cardiovascular risk screening that could lead to lifestyle modification and therapeutic intervention. Applying the new guideline criteria at least doubles the prevalence of women with hypertension postpartum.

Condensation

The new American College of Cardiology/American Heart Association guidelines will double the prevalence of hypertension postpartum.


 
  • References

  • 1 Whelton PK, Carey RM, Aronow WS. , et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 2018; 71 (06) 1269-1324
  • 2 Ford ES. Trends in mortality from all causes and cardiovascular disease among hypertensive and nonhypertensive adults in the United States. Circulation 2011; 123 (16) 1737-1744
  • 3 Smith GN, Pudwell J, Roddy M. The Maternal Health Clinic: a new window of opportunity for early heart disease risk screening and intervention for women with pregnancy complications. J Obstet Gynaecol Can 2013; 35 (09) 831-839
  • 4 Smith GN, Walker MC, Liu A. , et al; Pre-Eclampsia New Emerging Team (PE-NET). A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009; 200 (01) 58.e1-58.e8
  • 5 Cusimano MC, Pudwell J, Roddy M, Cho CK, Smith GN. The maternal health clinic: an initiative for cardiovascular risk identification in women with pregnancy-related complications. Am J Obstet Gynecol 2014; 210 (05) 438.e1-438.e9